Novartis将2028年的年销售增长率预测提高到6%,这是由新推出的药物推动的。 Novartis raises annual sales growth forecast to 6% through 2028, driven by new drug launches.

诺华公司将其预测的年销售增长率提高到6%,到2028年为止,在强劲的市场表现和即将推出的药物推动下,销售增长率从5%上升至6%。 Novartis raised its sales growth forecast to 6% annually through 2028, up from 5%, driven by strong market performance and upcoming drug launches. 该公司预计2024-2029年增长率为5%,2027年业务收入比值为40。 The company expects a 5% growth rate for 2024-2029 and a 40%+ operating income margin by 2027. 诺华大学正侧重于创新药品,有超过15份即将提交的药物和30多个资产正在编审中,目的是增加其投资组合,维持2029年以后的增长。 Novartis is focusing on innovative medicines, with over 15 upcoming drug submissions and more than 30 assets in its pipeline, aiming to boost its portfolio and sustain growth beyond 2029.

November 21, 2024

15 文章